Procalcitonin-guided antibiotics in severe sepsis

Affiliations

Comment

Peter Simon et al. Crit Care. 2008.

. 2008;12(6):309.

doi: 10.1186/cc7124. Epub 2008 Dec 4.

¹ Department of Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.

No abstract available

Comment on

Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial.
Nobre V, Harbarth S, Graf JD, Rohner P, Pugin J. Nobre V, et al. Am J Respir Crit Care Med. 2008 Mar 1;177(5):498-505. doi: 10.1164/rccm.200708-1238OC. Epub 2007 Dec 20. Am J Respir Crit Care Med. 2008. PMID: 18096708 Clinical Trial.

1. Eric B Milbrandt, editor. Evidence-Based Medicine Journal Club. EBM Journal Club Section;

1. Nobre V, Harbarth S, Graf JD, Rohner P, Pugin J. Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. Am J Respir Crit Care Med. 2008;177:498–505. doi: 10.1164/rccm.200708-1238OC. - DOI - PubMed
1. Meisner M. Pathobiochemistry and clinical use of procalcitonin. Clin Chim Acta. 2002;323:17–29. doi: 10.1016/S0009-8981(02)00101-8. - DOI - PubMed
1. Al Nawas B, Krammer I, Shah PM. Procalcitonin in diagnosis of severe infections. Eur J Med Res. 1996;1:331–333. - PubMed
1. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet. 1993;341:515–518. doi: 10.1016/0140-6736(93)90277-N. - DOI - PMC - PubMed
1. Castelli GP, Pognani C, Meisner M, Stuani A, Bellomi D, Sgarbi L. Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction. Crit Care. 2004;8:R234–R242. doi: 10.1186/cc2877. - DOI - PMC - PubMed